An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)
Clinical trial NCT07298239 · RECRUITING
Trial details
- NCT number
- NCT07298239
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-18
- Primary completion
- 2028-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.